SIGNATUREFD, LLC - ADAPTIMMUNE THERAPEUTICS PLC ownership

ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 81 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q2 2020. The put-call ratio across all filers is 1.08 and the average weighting 0.3%.

Quarter-by-quarter ownership
SIGNATUREFD, LLC ownership history of ADAPTIMMUNE THERAPEUTICS PLC
ValueSharesWeighting
Q4 2022$545
-81.8%
373
-88.3%
0.00%
Q3 2022$3,000
+200.0%
3,185
+312.6%
0.00%
Q2 2022$1,000
-50.0%
772
-31.5%
0.00%
Q1 2022$2,000
-87.5%
1,127
-73.4%
0.00%
Q4 2021$16,000
-27.3%
4,230
+0.5%
0.00%
-100.0%
Q3 2021$22,000
+2100.0%
4,207
+1778.1%
0.00%
Q2 2021$1,000
-80.0%
224
-76.3%
0.00%
Q1 2021$5,000
+400.0%
944
+321.4%
0.00%
Q4 2020$1,000
-75.0%
224
-39.9%
0.00%
Q2 2020$4,0003730.00%
Other shareholders
ADAPTIMMUNE THERAPEUTICS PLC shareholders Q2 2020
NameSharesValueWeighting ↓
NEA Management Company, LLC 15,832,611$68,080,0003.54%
Matrix Capital Management Company, LP 28,000,000$120,400,0003.21%
Virtus ETF Advisers LLC 50,655$218,0000.46%
TFG Asset Management GP Ltd 500,000$2,150,0000.27%
Rock Springs Capital Management LP 800,000$3,440,0000.13%
Orbimed Advisors 1,350,655$5,808,0000.09%
Vident Investment Advisory, LLC 289,340$1,244,0000.07%
WS MANAGEMENT LLLP 185,537$798,0000.05%
Rathbones Group PLC 285,722$1,229,0000.04%
Tekla Capital Management LLC 228,496$983,0000.04%
View complete list of ADAPTIMMUNE THERAPEUTICS PLC shareholders